Related Experiment Videos
HPV and pregnancy: diagnostic methods, transmission and evolution.
S Arena1, M Marconi, M Ubertosi
1Dipartimento di Scienze Ginecologiche, Ostetriche e Pediatriche, Università degli Studi, Perugia, Italy. arenasft@tin.it
Minerva Ginecologica
|June 14, 2002
Summary
Human papillomavirus (HPV) infection during pregnancy can lead to complications. While transmission to newborns is possible, the virus often clears within six months postpartum.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Virology
Background:
- Pregnancy can increase susceptibility to infections, including Human Papillomavirus (HPV).
- HPV infections during pregnancy present diagnostic challenges due to varying prevalence rates (5.4%–68.8%) and potential latency.
- Younger pregnant women, particularly those under 26, represent a high-risk demographic for HPV infection.
Purpose of the Study:
- To evaluate the relationship between HPV infection and pregnancy.
- To understand potential complications associated with HPV during gestation.
- To review diagnostic methods and transmission dynamics of HPV in pregnant populations.
Main Methods:
- Review of diagnostic techniques including clinical (gynecological exams, PAP-tests, colposcopy) and molecular methods (DNA assay, PCR, Hybrid Capture).
- Analysis of literature data on HPV prevalence, risk factors, and maternal-fetal transmission.
- Examination of the natural course of HPV infection in pregnancy and postpartum.
Main Results:
- Prevalence of HPV in pregnancy is highly variable, influenced by diagnostic methods, patient history, and sampling time.
- Maternal-fetal transmission of HPV is a documented concern, potentially causing juvenile laryngeal papillomatosis in newborns.
- Newborn HPV infections often resolve spontaneously within six months of birth.
Conclusions:
- Pregnancy can promote HPV development, which frequently regresses postpartum.
- Discrepancies in research findings are attributed to diverse diagnostic approaches and study parameters.
- Understanding HPV dynamics in pregnancy is crucial for managing potential maternal and neonatal health risks.